Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
about
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesSelf-assembly in monoelaidin aqueous dispersions: direct vesicles to cubosomes transition.Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticlesNovel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies.In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study.Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation.Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol.Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres.Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.Lipid-based supramolecular systems for topical application: a preformulatory study.Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery.Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.Blood glucose lowering property of water in oral insulin-fed diabetic rats.Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of FenofibrateOptimization of the Preparation Process for an Oral Phytantriol-Based Amphotericin B Cubosomes
P2860
Q26744008-EF050EE5-3FFC-472C-B5EE-18A817C33DE2Q33385136-4E6A281F-9B6C-4F54-94F9-D8AFD8A5BF83Q33557899-118573E4-111E-477D-8213-998E1FC723C3Q33573423-06267B2C-1917-474E-8E84-4DC88A104138Q33644850-8A0E0993-4B27-4655-9C60-4072CB9B0A36Q36015934-0277D0B8-272C-454D-9C2D-562A03A21480Q36237892-8A9D4A0A-9148-470F-A30F-1E3EA850C8F1Q36442187-D7856A86-F70E-4844-91BD-C50AE11B67E9Q36654312-0E9C2D6F-C6B8-4E83-91ED-C179EBEAB364Q36910413-D81D183D-8EAD-440B-8BC4-3317E0ECD980Q38076188-CF3B90F7-3289-42E7-9257-9417142F5CD4Q38948211-F67C0F22-1FE4-408F-A21C-E0B5A4F4CB32Q39147137-9BBB9D28-B089-4E7D-BC61-C699CBC95651Q41864793-A61A87E0-FE62-4657-BEBB-EB84C2A6B1F5Q42564617-54D22203-13A2-4AED-8FFA-7E99EBE2A14EQ44652079-1D82E63D-A5E7-4BF0-983D-37877A5E6D4FQ46186276-0F3BB949-9367-4D9E-BB95-C601E4007005Q50505324-97CF647C-429D-4FA4-8C63-D873AAF8BFC9Q57492599-60ED63AF-1296-4C35-8A6F-CD5B1888461DQ58691692-EE3FA599-C72D-4406-85B5-40EF7769377C
P2860
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
@en
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
@nl
type
label
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
@en
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
@nl
prefLabel
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
@en
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
@nl
P2093
P1433
P1476
Self-assembled "nanocubicle" as a carrier for peroral insulin delivery
@en
P2093
P2888
P304
P356
10.1007/S00125-001-0751-Z
P577
2002-03-01T00:00:00Z